Canopy Growth Q4 Loss Sharply Narrows - Quick Facts

Canopy Growth Corp. (CGC, WEED.TO) reported that its fourth-quarter net loss attributable to the company was C$699.98 million or C$1.85 per share, sharply narrower than C$1.30 billion or C$3.72 per share in the prior-year quarter.

On average, nine analysts polled by Thomson Reuters expected the company to report a loss of C$0.26 per share for the quarter. Analysts' estimates typically exclude special items.

Net revenue for the quarter grew to C$148.44 million from C$107.91 million in the same quarter last year. Analysts expected revenues of C$151.77 million for the quarter.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Flavor maker McCormick & Co., Inc. is recalling certain McCormick and Frank's brand seasoning products citing possible salmonella risk, the U.S. Food and Drug Administration said. The recall involves McCormick Perfect Pinch Italian Seasoning, McCormick Culinary Italian Seasoning and Frank's RedHot Buffalo Ranch Seasoning. Drug major Pfizer Inc. raised Wednesday its outlook for fiscal 2021 earnings and revenues following strong second quarter results that exceeded market estimates. According to the company, the upward revision in full-year outlook, for the second quarter in a row, reflects its updated expectations for contributions to 2021 performance from both BNT162b2, the Pfizer-BioNTech SE COVID-19 vaccine. While reporting financial results for the second quarter on Wednesday, biopharmaceutical company Bristol-Myers Squibb Co. (BMY) reaffirmed its adjusted earnings and revenue growth guidance for the full-year 2021. For fiscal 2021, the company now projects earnings in a range of $3.18 to $3.38 per share,...
Follow RTT